Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals
India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker    Newsletter   Tax Corner NRI Centre Forums E-Mail Chat Masala Feedback
my Last 5 Scrips
Company BSE Price(Rs) % Chg
Ntpc Ltd 150.25 1.08
Tata Stl 313.15 4.56
State Ba 2151.15 1.15
Tata Mot 288.10 0.93
Hindalco 107.10 1.70
Clear All Clear Last
Shares
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
Sector Watch
Economy Watch
Snapshot-Mangalam Drugs and Organics Limited
Mangalam Drugs and Organics Limited
Sector:Pharmaceuticals Pharmaceuticals - Pharmaceuticals - Others
BSE:532637NSE:MANGALAMBloomberg:MDOL@INReuters:MADR.BO
Market Lot: 1Face Value: 10ISIN Demat: INE584F01014
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
20-MAY-10 ICICI Securities has recommended `Buy` on JK Lakshmi Cement with a price target of Rs 77 as against the current market price (CMP) of Rs 65 in its report dated May 20, 2010. 02-MAR-10 JK Lakshmi Cement today reported a jump of 20.28% in sales at 4.27 lakh tones in February, reports agency source. 31-DEC-09 Credit rating agency, CARE has upgraded the rating assigned to the Long-term Bank Facilities and proposed NCD issue of JK Lakshm...   More..
Business Profile Future Plans
CEO Talk
Mangalam Drugs and Organics Ltd is coming out with a public issue of 65 lakh equity shares of face value Rs.10/- for cash at a price of Rs 22 each on April 19, 2005. The issue closes on April 26th, 2005. K.Seshadri of Myiris spoke to Govardhan M. Dhoot, Executive Chairman of the company to understand the company`s products, the market it operates in and the risks involved.  Govardhan M. Dhoot
One To One
Recent news
Latest News
Mangalam Drugs and Organics net surges 86.41% for Jun`10 qtr  -IRIS 29-Jul-10
Previous

 


Brief Financials (in Rs. Mn.) 
Period ending (months)30-Sep-2012(6)31-Mar-2012 (12)31-Mar-2011 (12)
Net sales 601.431531.821313.56
Other Income3.003.505.95
Total Income604.431535.321319.50
Cost of goods sold601.341390.981188.14
OPBDIT3.09144.34131.37
PAT-61.656.3420.88
Gross Block---
Equity capital131.78131.78131.78
EPS (Rs.)-0.481.58
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-19.98 - 33.636.43 - 14.30
Debt / Equity (x)---
Operating margin (% of OI) 0.5 9.410.0
Net margin (% of OI)-10.2 0.4 1.6
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
292, Princess Street
2nd Floor
Near Flyover
Marine Lines
Mumbai
Maharashtra-400 002
PHONE
(022) 2208 7969
FAX
(022) 2208 7074
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Trade On-line | Wealth Tracker | Newsletters | Tax Corner | NRI Centre | Forums | E-mail | Chat | Search in myiris | Advertise
© All rights reserved. IRIS Business Services Limited
Disclaimer